319 related articles for article (PubMed ID: 12514087)
1. Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis.
Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Zadik Z; Kula K; Slowikowska-Hilczer J; Rey R; Elliott DJ; Maymon BB
J Androl; 2003; 24(1):78-84. PubMed ID: 12514087
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
3. Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
Rey R; al-Attar L; Louis F; Jaubert F; Barbet P; Nihoul-Fékété C; Chaussain JL; Josso N
Am J Pathol; 1996 May; 148(5):1689-98. PubMed ID: 8623936
[TBL] [Abstract][Full Text] [Related]
4. Absence of RBM expression as a marker of intratubular (in situ) germ cell neoplasia of the testis.
Lifschitz-Mercer B; Elliott DJ; Leider-Trejo L; Schreiber-Bramante L; Hassner A; Eisenthal A; Maymon BB
Hum Pathol; 2000 Sep; 31(9):1116-20. PubMed ID: 11014580
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
6. Less advanced testicular dysgenesis is associated by a higher prevalence of germ cell neoplasia.
Guminska A; Oszukowska E; Kuzanski W; Sosnowski M; Wolski JK; Walczak-Jedrzejowska R; Marchlewska K; Niedzielski J; Kula K; Slowikowska-Hilczer J
Int J Androl; 2010 Feb; 33(1):e153-62. PubMed ID: 19719533
[TBL] [Abstract][Full Text] [Related]
7. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
[TBL] [Abstract][Full Text] [Related]
9. Mitotic activity of Sertoli cells in adult human testis: an immunohistochemical study to characterize Sertoli cells in testicular cords from patients showing testicular dysgenesis syndrome.
Brehm R; Rey R; Kliesch S; Steger K; Marks A; Bergmann M
Anat Embryol (Berl); 2006 Jun; 211(3):223-36. PubMed ID: 16429274
[TBL] [Abstract][Full Text] [Related]
10. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells.
Honecker F; Stoop H; de Krijger RR; Chris Lau YF; Bokemeyer C; Looijenga LH
J Pathol; 2004 Jul; 203(3):849-57. PubMed ID: 15221945
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes.
Kliesch S; Behre HM; Hertle L; Bergmann M
J Urol; 1998 Nov; 160(5):1894-8. PubMed ID: 9783981
[TBL] [Abstract][Full Text] [Related]
12. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
13. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer.
Słowikowska-Hilczer J; Szarras-Czapnik M; Kula K
J Androl; 2001; 22(5):781-92. PubMed ID: 11545290
[TBL] [Abstract][Full Text] [Related]
14. Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours.
Lobo MV; Arenas MI; Alonso FJ; Gomez G; Bazán E; Paíno CL; Fernández E; Fraile B; Paniagua R; Moyano A; Caso E
Cell Tissue Res; 2004 Jun; 316(3):369-76. PubMed ID: 15127288
[TBL] [Abstract][Full Text] [Related]
15. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development.
Honecker F; Kersemaekers AM; Molier M; Van Weeren PC; Stoop H; De Krijger RR; Wolffenbuttel KP; Oosterhuis W; Bokemeyer C; Looijenga LH
J Pathol; 2004 Oct; 204(2):167-74. PubMed ID: 15378486
[TBL] [Abstract][Full Text] [Related]
16. Intratubular germ cell neoplasia.
Gondos B; Migliozzi JA
Semin Diagn Pathol; 1987 Nov; 4(4):292-303. PubMed ID: 3328244
[TBL] [Abstract][Full Text] [Related]
17. Molecular markers for the assessment of postnatal male germ cell development in the mouse.
Jarvis S; Elliott DJ; Morgan D; Winston R; Readhead C
Hum Reprod; 2005 Jan; 20(1):108-16. PubMed ID: 15539445
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of neoplastic changes in germ cells as a developmental aspect].
Słowikowska-Hilczer J
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):37-42. PubMed ID: 17493405
[TBL] [Abstract][Full Text] [Related]
19. From carcinoma in situ to testicular germ cell tumour.
Donner J; Kliesch S; Brehm R; Bergmann M
APMIS; 2004 Feb; 112(2):79-88. PubMed ID: 15056223
[TBL] [Abstract][Full Text] [Related]
20. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
